VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Effects of cytochrome P-450 inhibitors on macrophage-induced oxidative modification of low density Lipoproteins

   
Dushkin M.I., Zenkov N.K., Pivovarova E.N., Lyubimov G.Yu., Menshikova Ye.B.
Section: Experimental Study
PubMed Id: 8783470
Year: 1996  Volume: 42  Issue: 1  Pages: 23-30
Unlike other cytochrome P450-dependent oxygenase inhibitors, ketoconazole has been shown to suppress the murine macrophage-mediated oxidative modification of human low-density lipoproteins (LDL) in a dose-dependent manner. The benzo[alpha]pyrene-induced microsomal monooxygenase activity was accomplished by a 1,5-fold increase in LDL oxidation by macrophages, ketokonazole (20 mu), methoxalene (20 mu), and alpha-naphthaflavone (50 mu). Ketoconazole was also effective in inhibiting macrophageal NADPH oxidase and LDL autooxidation induced by Fe2+ rather than Cu+, which is likely to be associated with its ability to act as a chelator of free and heme-bound iron ions.
Download PDF:  
Citation:

Dushkin, M. I., Zenkov, N. K., Pivovarova, E. N., Lyubimov, G. Yu., Menshikova, Ye. B. (1996). Effects of cytochrome P-450 inhibitors on macrophage-induced oxidative modification of low density Lipoproteins. Voprosy Meditsinskoi Khimii, 42(1), 23-30.
References  
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)